Form D · Other Health Care

Aliform Inc.

Dallas, TX · CIK 0001902467

Offering snapshot reported Jun 13, 2023 · SEC filing

Reported sold
$971K
Offering amount: $1.46M
Investors reported
7
Form D · investor count
Minimum accepted
$971K
Reported outside-investor minimum
First sale
May 30, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 13, 2023Initial$970,560No comparison7SEC filing
Jan 19, 2022Initial$30,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
04.1, 04.2, 04.3
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-484108
The investment came in the form of: (i) the conversion of certain debt into equity and (ii) a cash investment in two (2) tranches, the first of which is $970,560 and the second of which is $485,278.

Source: Form D, filed Jun 13, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Victor Suturin Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3000 Pegasus Park Dr. Suite 1330
Dallas, TX, 75247